role of braf mutation in the treatment for melanoma
Published 8 years ago • 615 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
4:18
development of novel treatments in melanoma patients with braf mutations
-
2:10
combined treatment with braf and mek inhibitors in metastatic melanomas with braf mutations
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
3:08
os rates and prognostic categories for braf-mutated melanoma when treated with combination therapy
-
2:29
braf mutated melanoma: targeted or immunotherapy?
-
3:03
what's the best option in the treatment of melanoma?
-
1:48
secombit – determining the order of sequential therapies in metastatic melanoma with braf mutations
-
30:22
the role of braf and other mutations in progression and malignant transformation, immune tolerance
-
27:28
advances in therapy for braf-mutant melanoma
-
5:14
braf mutations across cancers
-
2:40
neoadjuvant targeted therapy in braf v600 mutated melanoma
-
24:25
braf inhibition in melanoma tailoring the therapy to the tumor
-
9:24
anti-pd1 monotherapy or combination with ipi after braf/mek inhibitors in braf-mutant melanoma
-
2:10
using biomarkers to predict response to combination therapies in braf-mutant melanoma
-
0:43
richard kim, md, on the role of braf mutations in treatment of cholangiocarcinoma
-
4:07
understanding resistance to combined braf and mek inhibiton in melanoma and the significance of cdk4
-
6:43
a closer look at the role of braf in melanoma
-
0:55
the importance of biomarkers in treating melanoma patients
-
5:16
braf mutated melanoma